Geert Cauwenbergh - Net Worth and Insider Trading

Geert Cauwenbergh Net Worth

The estimated net worth of Geert Cauwenbergh is at least $14 dollars as of 2024-04-19. Geert Cauwenbergh is the President & CEO of Phio Pharmaceuticals Corp and owns about 22 shares of Phio Pharmaceuticals Corp (PHIO) stock worth over $14. Details can be seen in Geert Cauwenbergh's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Geert Cauwenbergh has not made any transactions after 2017-10-02 and currently still holds the listed stock(s).

Transaction Summary of Geert Cauwenbergh

To

Geert Cauwenbergh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Geert Cauwenbergh owns 3 companies in total, including Phio Pharmaceuticals Corp (PHIO) , DARA Biosciences Inc (DARA) , and CalEthos Inc (BUUZ) .

Click here to see the complete history of Geert Cauwenbergh’s form 4 insider trades.

Insider Ownership Summary of Geert Cauwenbergh

Ticker Comapny Transaction Date Type of Owner
PHIO Phio Pharmaceuticals Corp 2017-10-02 director & President and CEO
DARA DARA Biosciences Inc 2009-01-08 director
BUUZ CalEthos Inc 2008-04-03 director

Geert Cauwenbergh Latest Holdings Summary

Geert Cauwenbergh currently owns a total of 1 stock. Geert Cauwenbergh owns 22 shares of Phio Pharmaceuticals Corp (PHIO) as of October 2, 2017, with a value of $14.

Latest Holdings of Geert Cauwenbergh

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PHIO Phio Pharmaceuticals Corp 2017-10-02 22 0.64 14

Holding Weightings of Geert Cauwenbergh


Geert Cauwenbergh Form 4 Trading Tracker

According to the SEC Form 4 filings, Geert Cauwenbergh has made a total of 0 transactions in Phio Pharmaceuticals Corp (PHIO) over the past 5 years. The most-recent trade in Phio Pharmaceuticals Corp is the acquisition of 2 shares on October 2, 2017, which cost Geert Cauwenbergh around $4,500.

Insider Trading History of Geert Cauwenbergh

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Geert Cauwenbergh Trading Performance

GuruFocus tracks the stock performance after each of Geert Cauwenbergh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geert Cauwenbergh is -12.57%. GuruFocus also compares Geert Cauwenbergh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geert Cauwenbergh within 3 months outperforms 5 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Geert Cauwenbergh's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Geert Cauwenbergh

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.79 -12.57 -33.71 -68.6 -72.69 -73.89
Relative Return to S&P 500(%) -5.23 -14.65 -39.28 -78.16 -78.77 -82.74

Geert Cauwenbergh Ownership Network

Ownership Network List of Geert Cauwenbergh

No Data

Ownership Network Relation of Geert Cauwenbergh


Geert Cauwenbergh Owned Company Details

What does Phio Pharmaceuticals Corp do?

Who are the key executives at Phio Pharmaceuticals Corp?

Geert Cauwenbergh is the director & President and CEO of Phio Pharmaceuticals Corp. Other key executives at Phio Pharmaceuticals Corp include Chief Development Officer Gerrit Dispersyn , Chief Development Officer John A Barrett , and Chief Business Officer Alexey Eliseev .

Phio Pharmaceuticals Corp (PHIO) Insider Trades Summary

Over the past 18 months, Geert Cauwenbergh made no insider transaction in Phio Pharmaceuticals Corp (PHIO). Other recent insider transactions involving Phio Pharmaceuticals Corp (PHIO) include a net purchase of 13,215 shares made by Robert J Bitterman , and a net purchase of 9,000 shares made by Robert L Ferrara .

In summary, during the past 3 months, insiders sold 0 shares of Phio Pharmaceuticals Corp (PHIO) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Phio Pharmaceuticals Corp (PHIO) were sold and 7,810 shares were bought by its insiders, resulting in a net purchase of 7,810 shares.

Phio Pharmaceuticals Corp (PHIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Phio Pharmaceuticals Corp Insider Transactions

No Available Data

Geert Cauwenbergh Mailing Address

Above is the net worth, insider trading, and ownership report for Geert Cauwenbergh. You might contact Geert Cauwenbergh via mailing address: 1 Stults Drive, Plainsboro Nj 08536.

Discussions on Geert Cauwenbergh

No discussions yet.